Concourse Financial Group Securities, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
20 transactions
Others Institutions Holding EYPT
# of Institutions
163Shares Held
66.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$97.3 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$79.5 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$79.5 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$51.6 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$50.3 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $398M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...